The Paul-Ehrlich-Institut supports the German Cancer Consortium (Deutsches Konsortium für Translationale Krebsforschung, DKTK) and the German Center for Infectious Diseases (Deutsches Zentrum für Infektionsforschung, DZIF) during the development of new approaches and applications for the diagnosis, prevention and treatment of oncological and infectious diseases:
German Cancer Consortium (DKTK)
PEI supports DKTK by expert regulatory guidance to promote efficient translation of basic research findings into new treatment approaches of oncological and hematological malignancies.
German Center for Infectious Diseases (DZIF)
DZIF Office for Scientific and Regulatory Advice (DZIF-OSRA) located at the PEI: DZIF-OSRA provides support on scientific and regulatory aspects for innovative vaccines against infectious disease and anti-infectives